Hannah Linden, M.D.

Hannah Linden M.D.
faculty member

Hannah Linden, M.D.

Member
Clinical Research Division, Fred Hutch

Fax: 206.606.2023
Mailstop: G-3630

Dr. Hannah Linden is associate program director of the Medical Oncology and Hematology Fellowship Program at Fred Hutch and UW Medicine. She is a breast cancer specialist who treats patients at Seattle Cancer Care Alliance, the Hutch’s clinical-care partner, and Harborview Medical Center. Her clinical expertise is in hormone therapy, including treatments that target estrogen receptors. Dr. Linden also studies new breast cancer therapies and molecular imaging techniques, such as using PET scans to confirm the effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer. She is also interested in improving access to care in medically underserved, vulnerable populations.

Other Appointments & Affiliations

Professor of Medicine, Medical Oncology Division
University of Washington School of Medicine

Education

B.A., cum laude, Yale University, 1985

M.D., University of Massachusetts, 1989

Residency, University of Arizona Medical Center, 1989-1992

Fellowship, Pharmacology, University of Arizona Medical Center, 1992-1993

Fellowship, Hematology, University of Washington School of Medicine, 1993-1994

Senior Research Fellow, Hematology, University of Washington, 1994-2002

Research Interests

Understanding resistance and sensitivity to endocrine therapy of breast cancer, and identification of methods to overcome resistance

Pharmacodynamic imaging

Improving access to clinical trials

Improving outcomes for vulnerable populations

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210